SOUTH JORDAN, Utah, April 11, 2018 -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended March 31, 2018, after the close of the stock market on Wednesday, April 25, 2018.
Merit will hold its investor conference call (conference ID 8799557) on the same day (Wednesday, April 25, 2018) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). The telephone numbers to call are (domestic) (844) 578-9672; and (international) (508) 637-5656. A live webcast will also be available for the conference call at merit.com.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 5,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.
Contact: Anne-Marie Wright, Vice President, Corporate Communications
Phone: (801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688


AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Japan Earthquake Disrupts Auto and Chip Supply Chains
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
World game at war: why some European nations have threatened a World Cup boycott
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 



